WNT TO 5 — Wntresearch AB Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- SEK37.69m
- SEK1.11m
Annual income statement for Wntresearch AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 24.2 | 25.1 | 21.6 | 35.8 | 30.7 |
Operating Profit | -24.2 | -25.1 | -21.6 | -35.8 | -30.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -24.2 | -25.1 | -21.6 | -35.8 | -30.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -24.2 | -25.1 | -21.6 | -35.8 | -30.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -24.2 | -25.1 | -21.6 | -35.8 | -30.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -24.2 | -25.1 | -21.6 | -35.8 | -30.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.848 | -0.782 | -0.405 | -0.299 | -0.231 |
Dividends per Share |